RANK receptor expression by melanoma, breast and prostate cancer cell lines has also been described (Jones et al., 2006), and involved in the autocrine effect of tumor cell-derived RANKL on promoting cancer cell migration. The gene discussed is TNFSF11; the disease is neoplasm.